Kuehne+Nagel (K+N) has opened an airfreight cross-dock facility in Hyderabad as it looks to cater for rising pharma volumes from the city.
The new cross-dock measures 248 sq m and offers dedicated temperatures covering 2°C to 8°C and 15°C to 25°C.
The site also meets K+N’s global HealthChain quality standard, ensuring compliance with Good Practice healthcare standards.
“The investment strengthens the company’s ability to support the safe, compliant and reliable movement of healthcare products, in response to growing demand for specialised logistics solutions for pharmaceutical and medical shipments,” K+N said in a press release.
K+N said that Hyderabad is a major centre for pharmaceutical manufacturing, contributing over 40% of India’s active pharma ingredients and vaccine production.
Anish Kumar Jha, managing director for Kuehne+Nagel India, Sri Lanka and the Maldives, said: “This investment strengthens our healthcare logistics network in India and brings us closer to customers operating in one of the country’s most important pharmaceutical hubs.
“By investing in specialised, HealthChain-certified infrastructure, we are supporting Indian healthcare companies as they grow and connect to global markets through compliant, temperature-controlled supply chains.”
The facility is the forwarder’s second healthcare-certified facility in India after it launched its Bengaluru Cool Zone facility in December 2025.
The Bengaluru gateway handles consolidation and deconsolidation of cargo, streamlines customs processes, and provides temperature-controlled handling.
